TTTP =Tausend Tausend Tausend Prozent? - 500 Beiträge pro Seite

[morchel]

Hallo Zockergemeinde!
Tausen Prozent gibts nicht, vorerst, aber schnelle 100%-200% könnten es schon werden!

Schaut euch TTTP an.

eine Aktie an der 0,10$ Grundlinie!

Die haben ein sehr interessantes Bussiness.
Medikamenta auf natrlicher, zulassungsfreier Basis!

von viagraersatz bis zu natürlichen Antidepressiva ist alles vorhanden.

Das verstärkte Volumen in der letzten zeit hat mich veranlasst eine größere Position zu 0,10$ zu erwerben! eigentlich relativ gefahrlos wie ich denke, denn der chart hat die 0,10 immer gehalten1

Ich denke das in der nächsten Zeit big news anstehen werden. Man verhandelt ja mit vertriebspartnern in europa!

Zock as Zock can1

morchel

[silvodin]

Das ist also einer von den alten Sausäcken, die uns täglich mit Werbemails zumüllen.

[morchel]

Enlarge your Penis, Buy Vigara,

Nein....die sind noch auf der Suche nach einem Vertriebspartner, und der müllt euch dann zu!

morchel

[morchel]

und los gehts...in den ersten Minuten den halben Tagesumsatz von gestern!

+15%

morchel

[alexis74]

volumenalarm!!!

schon 340.000 stück gehandelt in den ersten minuten...

[alexis74]

Volles Oder buch in Berlin:

Kauf Orders
Stücke Limit
1.000 0,12
1.250 0,11
3.700 0,08
50.000 0,05

es wird allerdings nichts ausgeführt!

[alexis74]

komische wkn in berlin...

WKN: A0BK2C


wer denkt sich so blöde wkn`s aus?

[blabla3003]

(OTCBB: TTTP) is New to TheSUBWAY.com


Shares: Attractive



COMPANY OVERVIEW




12 to 20 Plus, Inc. (OTCBB: TTTP) is a company that produces and markets (through its Neurochemical Research Group division) highly effective supplements, often referred to as neutraceuticals. The products, manufactured by FDA-approved labs, contain a sophisticated combination of extensively researched nutritional elements available and do not contain herbs. Retail sales in the explosive dietary supplement market are expected to hit $21 billion by the year 2007, according to Frost & Sullivan reports.
While growth of general dietary supplements such as vitamins and minerals has slowed over recent years, specialty dietary supplements have continued to experience markedly increased sales. Consumers are becoming more health conscious and are choosing to play a more active role in preventing and treating their medical conditions. The availability of scientific evidence supporting the safety and efficiency of the company`s specialty dietary supplements has made their products attractive to self-help oriented purchasers.

12 to 20 Plus spent years in the research and development of a "spa style" Acne Therapy System™. Utilizing a high tech with natural overtones product development technology, the system delivers sensitive, but powerful treatment. One of the products is ZitStick®, an on-the-go medication. The market for acne remedies, which are always in demand, in the drug, mass and supermarket channels is expected to reach $370 million in 2004.

The Products

12 to 20 Plus utilizes potent pharmaceutical grade amino acids, important protein constituents that serve as neurotransmitter precursors, membrane stabilizers and enzyme precursors. For energy production and other body functions, the utilization of amino acids is improved by providing the proper nutrients, such as antioxidants, to support their activities.

Formulae proprietary to 12 to 20 Plus include:

Anaplex™, the antidepressant drug alternative;
VisionKare™ advanced supplement for macular degeneration;
ChemoKare™ unique composition of widely studied grape seed extracts offering chemoprotective, antioxidant and biological properties:
QuitSystem® neuronutrient supplementation for recovery from alcohol, drugs and smoking;
Trim-A-Way® Weight Control & Body Shaper supplements;
Male Virility Natural alternative to Viagra.
The company is projecting $30 million in sales over the next 36 months with its advanced eye therapy, VisionKare™ whose composition has been validated by a National Eye Institute one-year research study.

12 to 20 Plus will be marketing a complete Acne Therapy System™ for the prevention, control and treatment of acne skin conditions. Dual-purpose product benefits will be promoted in advertising that will position the products as medicated cosmetics, which enhance and beautify skin while working to clear and control acne related skin problems.

On the cutting edge of new technology, 12 to 20 Plus products offer advanced, superior quality ingredients for the prevention, control and treatment of acne skin conditions. The Zit Stick® and Pimple Pencil product line utilize a spa-based technology which means treatments that are deeper than skin deep.

A recent survey shows that 67 percent of acne treatments purchased are over-the-counter medications. 12 to 20 Plus can capitalize in this market by exploiting the fact that products currently on the market are harsh and abrasive on the skin. 12 to 20 Plus offers an alternative; acne relief without excessive irritation and drying of the skin.

The complete system of product use is key to the marketing concept. The 12 to 20 Plus system is gentle enough for daily use and primarily designed to help control and prevent acne conditions from taking over.

The Markets

Although vitamins are the leading category, specialty supplements are driving growth; 2000 sales of specialty dietary supplements were roughly $1.65 billion. The compound average growth rate for specialty supplements from 1995 to 2000 was 18.7 percent, far outpacing growth in the overall supplement market.

SPINS, a San Francisco-based market research firm, in conjunction with A.C. Nielsen, states retail sales of specialty supplements through mainstream stores and natural supermarkets to be roughly $551 million in the 12 month period from June 2000 through May 2001. Future sales growth is likely to come from the migration of occasional to regular users of dietary supplements, suggests Health Business Partners.

In a report by researcher Frost & Sullivan, consumers` continuing desire to maintain their own health and appearance without the use of synthetic drugs has led to an explosion in sales of natural dietary supplements. Increasing scientific evidence supports the growth of this trend says Frost & Sullivan. The report goes on to state that the US natural dietary supplements market generated revenues of $6.67billion in 2000. Frost & Sullivan projects this figure to top $21 billion by 2007.

According to AC Nielsen sales of acne remedies in the drug, mass and supermarket channels reached $343 million in the 52-week period ended May 19, 2001. The medicated skin care market increased 7.9% in food channels with sales in excess of $88 million; 12.7% at drug stores bumping sales to about $95 million and experienced a 16.8% gain at mass merchants where sales exceed $120 million. The international market for acne remedies is estimated at another $400 million, bringing the total potential market to around $800 million worldwide.

Strategic Relationships

12 to 20 Plus has a national sales broker network comprised of 22 offices nationwide (including Alaska and Hawaii) in line to sell-in to all three channels of distribution. Additionally, 12 to 20 Plus will participate in e-commerce with Drug Store.com and Beauty Online where consumer spending on skin care, cosmetics and fragrances is expected to jump to $553 million in 2003. The company will launch a marketing campaign to dermatologists via direct mail efforts and educational Web sites.

12 to 20 Plus has begun to build its Anaplex™ brand with distribution in Longs Drug Stores, a recognized leader in the chain drug industry trading on the NYSE (LDG) since 1971 and one of the top ten chains in the Western States with over 400 stores. Anaplex brand was shipped to AmerisourceBergen Services Corporation (NYSE: ABC) for distribution to Longs. The division has run full page, full color consumer ads advertising Anaplex in Alternative Medicine magazine and Psychology Today and has planned insertions in T Magazine, Newsweek Health Showcase editions and People Magazine.

Management

12 To 20 Plus is comprised of a world class management team that has the experience and successful track record of building businesses in various industries. Their combined experience of over 100 years, is an integral part of Neurochemical’s unique vision of the specialty dietary supplement industry. The management team combines experience in the areas of pharmaceuticals, marketing, sales and administration and is lead by Carol Slavin, who personally brings over 26 years of management experience from various industries including consumer product goods.

Outlook

Today`s $6.5 billion vitamins, minerals, and neutraceuticals markets` growth potential is projected to surpass $20 billion in retail sales by year 2007. According to market research, supplements will dominate the surging vitamin and minerals market. Chain drug store pharmacies are forecast to account for more than 50 percent of this category volume as physicians and pharmacists nationwide are fueling the direction toward alternative therapy.

Marketing research, product development, Beta testing and various mergers and acquisitions in 2003, has now positioned 12 to 20 Plus to roll out its full product line of preventative health care products into the multi-billion dollar Over the Counter (OTC) market. 12 To 20 Plus is ready to capitalize on its exceptional product line.

In addition, the company recently announced the acquisition of H. Bana Ltd., a private corporation from Las Vegas, that has formulated and proven through clinical trials its natural polysaccharides containing solutions for thinning hair. Hinoki Bana is a complex formulation of natural plant polysaccharides extracted through a patented process. The Hinoki Bana product line is a natural match for the wellness oriented philosophy of TTTP. The acquisition gives the company an entree into the lucrative hair regrowth market segment. The Hinoki Bana product mix, applied topically, underwent extensive clinical trials in June of 2000 demonstrating the products as efficacious with a 92% satisfaction rate among both men and women participants. TTTP plans a targeted 3rd quarter 2004 rollout for Hinoki Bana natural hair regrowth products. The acquisition shows that TTTP is on the right way of establishing an attractive business in a high growth market.

[maxpayne2]

12 to 20 Plus (OTC BB: TTTP) and Venture Capital Resource, Ltd Enter Into a Stock Purchase Agreement

Tuesday , February 10, 2004 06:03 ET

SAN LUIS OBISPO, CA, Feb. 10, 2004 (MARKET WIRE via COMTEX) -- Carol Slavin, President of 12 to 20 Plus, Incorporated (OTC BB: TTTP), (Berlin Bourse:TVZ), today announced that it has entered into a stock purchase agreement with Venture Capital Resource, Ltd, a private firm to buy 400,000 newly issued shares of its common stock, restricted pursuant to Rule 144, at a purchase price of $.15 per share, resulting in net proceeds to the Company of $60,000. The transaction was funded and effective 12/31/03.

Said Jay Smith, President of Venture Capital Resource, Ltd, "We have had an on-going relationship with 12 to 20 Plus in another capacity as their representative in the Mergers & Acquisitions sector and feel confident this will be a successful enterprise. Our agreement is to fund the company on a best efforts basis an additional $440,000 over the next 90 days."

The net proceeds of the offering will be added to working capital and used for general corporate purposes. The company may also use a portion of the net proceeds to fund acquisitions of complementary businesses, products or technologies. However, 12 to 20 Plus has no present understandings, commitments or agreements to enter into any such potential acquisitions.

The Markets

Today`s $6.5 billion vitamins, minerals, and neutraceuticals markets` growth potential is projected to surpass $20 billion in retail sales by year 2007. According to market research, supplements will dominate the surging vitamin and minerals market. Chain drug store pharmacies are forecast to account for more than 50 percent of this category volume as physicians and pharmacists nationwide are fueling the direction toward alternative therapy.

In a report by researcher Frost & Sullivan, consumers` continuing desire to maintain their own health and appearance without the use of synthetic drugs has led to an explosion in sales of natural dietary supplements. Increasing scientific evidence supports the growth of this trend says Frost & Sullivan. The report goes on to state that the US natural dietary supplements market-generated revenues of $6.67 billion in 2000. Frost & Sullivan projects this figure to top $21 billion by 2007.

According to AC Nielsen, sales of acne remedies in the drug, mass and supermarket channels reached $343 million in the 52-week period ended May 19, 2001. The medicated skin care market increased 7.9% in food channels with sales in excess of $88 million; 12.7% at drug stores bumping sales to about $95 million and experienced a 16.8% gain at mass merchants where sales exceed $120 million. The international market for acne remedies is estimated at another $400 million, bringing the total potential market to around $800 million worldwide.

Chain drug store pharmacies are forecast to account for more than 50 percent of this category volume as physicians and pharmacists nationwide are fueling the direction toward alternative therapy. 12 to 20 Plus has begun to build its Anaplex(TM) brand with distribution in Longs Drug Stores, a recognized leader in the chain drug industry trading on the NYSE.

12 to 20 Plus, Inc. has spent years in the research and development of a "spa style" acne therapy system(TM). Utilizing a high tech with natural overtones product development technology, the system delivers sensitive, but powerful treatment. One of the products is Zit Stick(R), an on-the-go medication. The market for acne remedies, which are always in demand, in the drug, mass and supermarket channels, is expected to reach $370 million in 2004.

Its Neurochemical Research Group (NRG) division markets highly effective condition-specific dietary supplements containing the most sophisticated combination of extensively researched nutritional elements available. The products, manufactured by FDA-approved labs, do not contain herbs. The Company utilizes potent pharmaceutical grade "amino acids," important protein constituents that serve as neurotransmitter precursors, membrane stabilizers and enzyme precursors. For energy production and other body functions, the utilization of amino acids is improved by providing the proper nutrients, such as antioxidants to support their activities.

Marketing research, product development, Beta testing and various mergers and acquisitions in 2003, has now positioned 12 to 20 Plus to roll out its full product line of preventative health care products into the multi-billion dollar Over the Counter (OTC) market. 12 to 20 Plus is ready to capitalize on its exceptional product line.

Proprietary Formulae and Web site: www.neurochemicalresearch.com.

QuitSystem(R) neuronutrient supplementation for recovery from alcohol, drugs and smoking.

Anaplex(TM), the antidepressant drug alternative.

VisionKare(TM), advanced supplement for macular degeneration.

Trim-A-Way(R), body shaper supplements.

Male Virility (TM) natural alternative to Viagra.

Hinoki Bana(TM) natural hair regrowth products.

This press release contains forward-looking statements about events and circumstances that have not yet occurred. For example, words such as "will," "can," "expects," "enables," "believes" or other statements in the future tense, are forward-looking statements. Actual outcomes and results may differ materially from expectations in this press release due to a number of risks and uncertainties. Such risks and uncertainties include whether the market for 12 to 20 Plus products will grow as projected, if at all, whether demand for OTC products will continue as forecasted. I R Contact: Venture Capital Resource, Ltd. at 775-827-4557, or [e-mail].


I R Contact:
Attn: Jay Smith
Venture Capital Resource, Ltd.
775-827-4557
[e-mail]

[morchel]

NEWS NEWS NEWS
Aktien werden um 40% über dem gegenwärtigen Kurswert gekauft!

2004-02-10 06:00 ET - News Release

SAN LUIS OBISPO, CA -- (MARKET WIRE) -- 02/10/04

Carol Slavin, President of 12 to 20 Plus, Incorporated (OTC BB: TTTP), (Berlin Bourse:TVZ), today announced that it has entered into a stock purchase agreement with Venture Capital Resource, Ltd, a private firm to buy 400,000 newly issued shares of its common stock, restricted pursuant to Rule 144, at a purchase price of $.15 per share, resulting in net proceeds to the Company of $60,000. The transaction was funded and effective 12/31/03.

Said Jay Smith, President of Venture Capital Resource, Ltd, "We have had an on-going relationship with 12 to 20 Plus in another capacity as their representative in the Mergers & Acquisitions sector and feel confident this will be a successful enterprise. Our agreement is to fund the company on a best efforts basis an additional $440,000 over the next 90 days."

The net proceeds of the offering will be added to working capital and used for general corporate purposes. The company may also use a portion of the net proceeds to fund acquisitions of complementary businesses, products or technologies. However, 12 to 20 Plus has no present understandings, commitments or agreements to enter into any such potential acquisitions.

morchel

[morchel]

und zusätzlich macht auch noch The subway Stimmung für TTTP:

WESTON, Fla., Feb. 10, 2004 (PRIMEZONE) -- TheSUBWAY.com names 12 To 20 Plus Inc. (OTCBB:TTTP) to its Stock Watch List. TTTP is new to TheSUBWAY.com, and we expect great things from this stock! Watch this company; we think it is due to make a move in the near term!

morchel

[morchel]

Das Bid ist in USA jedenfalls sehr stark...könnte sein das TTTP wegen der Empfehlung von "The subway" explodiert!

morchel

[morchel]

In Berlin zeigt das Orderbuch schon erste Kauforder!

mit 0,1 über dem Kurs in USA

morchel

[morchel]

kann heute exrem hochlaufen wenn ich mir Level2 so ansehe

morchel

[morchel]

Da kann man mal schnelle 50% abschöpfen...obwohl es auch gute Aussichten für Langfristanleger gibt1

morchel

[morchel]

und das Ask wird immer schwächer...

Heute gehts ab!

morchel

[morchel]

jetzt schon 3 Kursmakler bei 0,11 im Bid

gestern nur 1 Kursmakler bei 0,095

und aus dem Ask werden ständig Orders entfernt.

das Ding ist Ruckzuck bei 0,15

morchel

[morchel]

4 Kursmakler bei 0,11

Verkaufsorder zu 0,12 wurde entfernt!

neues Ask 0,13

morchel

[morchel]

Bid 0,125

morchel

[morchel]

Ask 0,135

morchel

[kalock]

Nachdem der Threadpapa inzwischen woanders morchelt
oute ich mich mal als 12to20KA (gestern zu 10,5 Cent)
Lustigerweise hab ich erst nachher gelesen daß der Cashbestand der Fa im Sept03 680 USD betrug.
( oder war das x 1000 gemeint? )

Es kann also nur besser werden, und der Chart lässt dies erhoffen.

[morchel]

+60%



ich bin erstmal raus!

morchel

[kalock]

morchel, zumindest den Thread hast du noch im Auge
auch wenn man dich nicht wirklich engagiert nennen kann
freu mich natürlich über die heutige Explosion
die mich supi aus dem zwischenzeitlichen Minus gebracht hat
( den Tiefpunkt hab ich ja leider nicht erwischt )

[kalock]

morchel, Gewinne laaufen lassen, heißts immer....
ging die letzten 2 Tage gut weiter
100% in 3 Tagen

[morchel]

Gratuliere!

Wenigstens einer der ausser mir noch profitiert hat!

morchel

[kalock]

Die w:o Gemeinde dürfte diesen Hit verschlafen haben
in 8 Tagen machte das Ding 160 %
gestern kam ne Meldung mit ner neuen Produkteinführung
jetzt sollte ich auch langsam den Gewinn sichern

[morchel]

heute gehts wieder über .20



morchel